EUVIMEDEUVIMED entdecken
Editorial

Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases

Ingrid Fricke-Galindo iD, Ramcés Falfán-Valencia iD

Pharmacogenomics · 2023

DOI: 10.2217/pgs-2023-0036 ↗

Kurz gefasst

Editorial in der Zeitschrift Pharmacogenomics, 2023. Verfasst von Ingrid Fricke-Galindo und 1 weiteren Autor:innen. Beteiligte Einrichtung: HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, 14080, Mexico. Hauptthemen laut MEDLINE: Pharmacogenetics, Respiratory Tract Diseases. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tweetable abstract Opportunities for pharmacogenetics implementation in chronic respiratory diseases through the employment of genotype-guided prescriptions in treating nonrespiratory comorbidities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PharmacogeneticsRespiratory Tract DiseasesHumansGenotype

Stichwörter der Autor:innen

anticoagulantsasthmachronic obstructive pulmonary diseasepharmacogenomicssmokingstatins

Autor:innen und Institutionen

  • HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, 14080, Mexico.

ORCID-Profile: Ingrid Fricke-Galindo, Ramcés Falfán-Valencia

Zitieren

APA

Fricke-Galindo, I., & Falfán-Valencia, R. (2023). Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases. Pharmacogenomics. https://doi.org/10.2217/pgs-2023-0036

Vancouver

Fricke-Galindo I, Falfán-Valencia R. Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases. Pharmacogenomics. 2023. doi:10.2217/pgs-2023-0036

BibTeX
@article{FrickeGalindo2023,
  author = {Fricke-Galindo, Ingrid and Falfán-Valencia, Ramcés},
  title = {Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases},
  journal = {Pharmacogenomics},
  year = {2023},
  doi = {10.2217/pgs-2023-0036}
}
Kostenlos starten →